GenMark
The core features have stayed consistent as GenMark is "dedicated to the syndromic approach" and remains focused on infectious diseases, a Roche executive said.
At the AMP annual meeting this week, the company outlined its technology and vision for a speedy, low-cost, high-accuracy diagnostic.
There were 39 total mergers and acquisitions in the first six months of 2021, with two deals topping out over $1 billion.
Roche Diagnostics Q1 Sales Climb 50 Percent
The firm's diagnostics growth was driven by COVID-19 test sales with point-of-care sales skyrocketing year over year.
360Dx Index Declines 2 Percent in March, Continuing Downward Slope
Of the 31 companies in the index, 11 firms saw their stock prices increase, while 20 saw their share prices decline.
Mar 16, 2021
Mar 15, 2021
Roche to Acquire GenMark Diagnostics for $1.8B
Feb 11, 2021